Dissolution thermodynamics and solubility of silymarin in PEG 400-water mixtures at different temperatures

Drug Development and Industrial Pharmacy

Volumn 41, Issue 11, 2015, Pages 1819-1823

  Shakeel, Faiyaz ^a,b   Anwer, Md Khalid ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Apelblat equation; Dissolution thermodynamics; Silymarin; Solubility; Yalkowsky model

Indexed keywords

MACROGOL 400; SILYMARIN; SOLVENT; WATER; MACROGOL DERIVATIVE;

ANALYSIS; APELBLAT EQUATION; APELBLAT MODEL; ARTICLE; DRUG MIXTURE; DRUG SOLUBILITY; DRUG STRUCTURE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PRESSURE; TEMPERATURE; THERMODYNAMICS; VAN'T HOFF KRUG ANALYSIS; YALKOWSKY MODEL; CHEMICAL MODEL; CHEMISTRY; SOLUBILITY;

MODELS, CHEMICAL; POLYETHYLENE GLYCOLS; SILYMARIN; SOLUBILITY; SOLVENTS; TEMPERATURE; THERMODYNAMICS; WATER;

EID: 84937558567     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2015.1009914     Document Type: Article

References (30)

1. Cook NC, Samman S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 1996; 7: 66-76.
2. Srinivas K, King JW, Howard LR, Monrad JK. Solubility and solution thermodynamic properties of quercetin and quercetin dehydrate in subcritical water. J Food Eng 2010; 100: 208-18.
3. Woo JS, Kim TS, Park JH, Chi SC. Formulation and biopharma-ceutical evaluation of silymarin using SMEDDS. Arch Pharm Res 2007; 30: 82-9.
4. Kvasnicka F, Biba B, Sevcik R, et al. Analysis of the active components of silymarin. J Chromatogr A 2003; 990: 239-45.
5. Javed S, Kohli K, Ali M. Reassessing bioavailability of silymarin. Alternat Med Rev 2011; 16: 239-49.
6. Ghosh A, Biswas S, Ghosh T. Preparation and evaluation of silymarin β-cyclodextrin molecular inclusion complexes. J Young Pharm 2011; 3: 205-10.
7. Shakeel F, Anwer MK, Shazly GA, Jamil S. Measurement and correlation of solubility of bioactive compound silymarin in five different green solvents at 298.15 K to 333.15 K. J Mol Liq 2014; 195: 255-8.
8. Anwer MK, Al-Shdefat R, Jamil S, et al. Solubility of bioactive compound hesperidin in six pure solvents at (298.15 to 333.15) K. J Chem Eng Data 2014; 59: 2065-9.
9. Jassbi AR, Miri R, Asadollahi M, et al. Cytotoxic, antioxidant and antimicrobial effects of nine species of woundwort (Stachys) plants. Pharm Biol 2014; 52: 62-7.
10. Soltanpour S, Jouyban A. Solubility of lamotrigine in binary and ternary mixtures of N-methyl pyrrolidone and water with polyethylene glycols 200, 400 and 600 at 298.2K. J Mol Liq 2013; 180: 1-6.
11. Shakeel F, Alanazi FK, Alsarra IA, Haq N. Solubility prediction of indomethacin in PEG 400 + water mixtures at various temperatures. J Mol Liq 2013; 188: 28-32.
12. Shakeel F, Alanazi FK, Alsarra IA, Haq N. Solubility of antipsychotic drug risperidone in Transcutol + water co-solvent mixtures at 298.15 to 333.15K. J Mol Liq 2014; 191: 68-72.
13. Shakeel F, Alanazi FK, Alsarra IA, Haq N. Thermodynamics-based mathematical model for solubility prediction of glibencla-mide in ethanol-water mixtures. Pharm Dev Technol 2014; 19: 702-7.
14. Shakeel F, Haq N, Alanazi FK, Alsarra IA. Thermodynamic modeling for solubility prediction of indomethacin in self-nanoemulsifying drug delivery system (SNEDDS) and its individual components. Drug Dev Ind Pharm 2014; 40: 1240-5.
15. Duan RL, Sun X, Liu J, et al. Mixed micelles loaded silybin-polyene phosphatidylcholine complex improving solubility. Acta Pharm Sinica 2011; 32: 108-15.
16. Sonali D, Tejal S, Vaishali T, Tejal G. Silymarin-solid dispersions: characterization and influence of preparation methods on dissolution. Acta Pharm 2010; 60: 427-43.
17. Yu JN, Yuan Z, Wang L, et al. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/ phospholipid-mixed micelles. Acta Pharm Sinica 2010; 31: 759-64.
18. Li X, Yuan Q, Huang Y, et al. Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS PharmSciTech 2010; 11: 672-8.
19. Lian R, Lu Y, Qi J, et al. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability. AAPS PharmSciTech 2011; 12: 1234-40.
20. Panapisal V, Charoensri S, Tantituvanont A. Formulation of microemulsion systems for dermal delivery of silymarin. AAPS PharmSciTech 2012; 13: 389-99.
21. Parveen R, Baboota S, Ali J, et al. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage. Arch Pharm Res 2011; 34: 767-74.
22. Huang X, Wu Z, Gao W, et al. Polyamidoamine dendrimers as potential drug delivery carriers for enhanced aqueous solubility and oral bioavailability of silybin. Drug Dev Ind Pharm 2011; 37: 419-27.
23. Dube D, Khatri K, Goyal AK, et al. Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin. Drug Dev Ind Pharm 2010; 36: 547-55.
24. Apelblat A, Manzurola E. Solubilities of L-aspartic, DL-aspartic, DL-glutamic, p-hydroxybenzoic, o-anisic, p-anisic, and itaconic acids in water from T = 278 K to 345 K. J Chem Thermodyn 1997; 29: 1527-33.
25. Apelblat A, Manzurola E. Solubilities of o-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic and p-toluic acid and magnesium-DL-aspartate in water from T = (278 to 348) K. J Chem Thermodyn 1999; 31: 85-91.
26. Manzurola E, Apelblat A. Solubilities of L-glutamic acid, 3-nitrobenzoic acid, acetylsalicylic, p-toluic acid, calcium-L-lactate, calcium gluconate, magnesium-DL-aspartate, and magnesium-L-lactate in water. J Chem Thermodyn 2002; 34: 1127-36.
27. Yalkowsky SH, Roseman TJ. Solubilization of drugs by cosolvents. In: Yalkowsky SH, ed. Techniques of solubilization of drugs. New York: Marcel Dekker, Inc.; 1981: 91-134.
28. Holguín AR, Rodríguez GA, Cristancho DM, et al. Solution thermodynamics of indomethacin in propylene glycol + water mixtures. Fluid Phase Equilibria 2012; 314: 134-9.
29. Ruidiaz MA, Delgado DR, Martínez F, Marcus Y Solubility and preferential solvation of indomethacin in 1,4-dioxane + water solvent mixtures. Fluid Phase Equilibria 2010; 299: 259-65.
30. Krug RR, Hunter WG, Grieger RA. Enthalpy-entropy compensation. 2. Separation of the chemical from the statistic effect. J Phys Chem 1976; 80: 2341-51.